Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Silo Pharma (SILO) over the last 7 years, with Q3 2025 value amounting to -$95474.0.

  • Silo Pharma's Cash from Investing Activities fell 13613.47% to -$95474.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 7929.63%. This contributed to the annual value of $973777.0 for FY2024, which is 12348.09% up from last year.
  • Silo Pharma's Cash from Investing Activities amounted to -$95474.0 in Q3 2025, which was down 13613.47% from $388102.0 recorded in Q2 2025.
  • Silo Pharma's 5-year Cash from Investing Activities high stood at $6.8 million for Q3 2021, and its period low was -$6.0 million during Q1 2023.
  • Moreover, its 5-year median value for Cash from Investing Activities was $66707.0 (2022), whereas its average is $309994.8.
  • As far as peak fluctuations go, Silo Pharma's Cash from Investing Activities soared by 13537140.0% in 2021, and later plummeted by 3014169.5% in 2023.
  • Silo Pharma's Cash from Investing Activities (Quarter) stood at $349456.0 in 2021, then plummeted by 80.91% to $66707.0 in 2022, then skyrocketed by 6539.34% to $4.4 million in 2023, then crashed by 100.85% to -$37659.0 in 2024, then crashed by 153.52% to -$95474.0 in 2025.
  • Its Cash from Investing Activities stands at -$95474.0 for Q3 2025, versus $388102.0 for Q2 2025 and $871381.0 for Q1 2025.